Dianthus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNTH and other ETFs, options, and stocks.

About DNTH

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. 

CEO
Marino Garcia
CEOMarino Garcia
Employees
78
Employees78
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2015
Founded2015
Employees
78
Employees78

DNTH Key Statistics

Market cap
574.06M
Market cap574.06M
Price-Earnings ratio
-6.13
Price-Earnings ratio-6.13
Dividend yield
—
Dividend yield—
Average volume
271.91K
Average volume271.91K
High today
$18.45
High today$18.45
Low today
$17.49
Low today$17.49
Open price
$17.85
Open price$17.85
Volume
90.96K
Volume90.96K
52 Week high
$32.27
52 Week high$32.27
52 Week low
$13.37
52 Week low$13.37

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own DNTH. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Pfizer
Plug Power
Alibaba
Tilray Brands
Inovio
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.